Plasmid-encoded IL-12 (Inovio Pharmaceuticals/The Wistar Institute/University of Pennsylvania/Public Health Agency of Canada/University of Guelph)

N/A

Report date: 2025/01/26 16:10:08

Base Information

Drug NamePlasmid-encoded IL-12 (Inovio Pharmaceuticals/The Wistar Institute/University of Pennsylvania/Public Health Agency of Canada/University of Guelph)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionInterleukin-12 modulators
TargetsInterleukin-12
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A